Page last updated: 2024-11-04

temazepam and Atherosclerotic Parkinsonism

temazepam has been researched along with Atherosclerotic Parkinsonism in 1 studies

Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.

Research Excerpts

ExcerptRelevanceReference
"Temazepam was consistently less potent than chlormethiazole on tests of drowsiness and psychomotor performance."2.67A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients. ( Ashwood, TJ; Bateman, DN; Tulloch, JA; Woodhouse, KW, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tulloch, JA1
Ashwood, TJ1
Bateman, DN1
Woodhouse, KW1

Trials

1 trial available for temazepam and Atherosclerotic Parkinsonism

ArticleYear
A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients.
    Age and ageing, 1991, Volume: 20, Issue:6

    Topics: Aged; Benserazide; Carbidopa; Chlormethiazole; Double-Blind Method; Drug Therapy, Combination; Femal

1991